Sradha Kotwal's Publications

About Sradha Kotwal's Publications

Program Head, Renal and Metabolic Division

  • WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK

    Kidney International Reports Date published:

  • WCN25-1567 Glomerular disease registry and Biobank (GRIT)- design and baseline results

    Kidney International Reports Date published:

  • Risk factors associated with 30-day mortality following COVID -19 infection in patients receiving kidney replacement therapy in Australian and New Zealand

    Internal Medicine Journal Date published:

  • Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD

    Kidney International Reports Date published:

  • The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design

    JAMA Network Open Date published:

  • Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis

    Journal of the American Society of Nephrology Date published:

  • Effects of Semaglutide on CKD in Patients With Type 2 Diabetes

    Kidney International Reports Date published:

  • Assessing the Quality of Care for People with CKD: A Systematic Review and Meta-Analysis

    Journal of the American Society of Nephrology Date published:

  • National Estimates of Direct Health Care Costs Associated with Catheter-Related Bloodstream Infection among Hospitalized Hemodialysis Patients in Australia

    Journal of the American Society of Nephrology Date published:

  • Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status

    Journal of the American Society of Nephrology Date published:

  • Risk-Based Implementation of SGLT2 Inhibitors: Insights from the CANVAS Program and CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial

    Journal of the American Society of Nephrology Date published:

  • Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial

    BMJ Open Date published:

  • Kidney Disease as a Cardiovascular Disease Priority

    Circulation Date published:

  • Replacement Strategies for Tunneled Hemodialysis Catheters with Complications: A Nationwide Cohort Study

    Clinical Journal of the American Society of Nephrology Date published: